Micro Emerging Active

GILD strengthens inflammation and autoimmunity pipeline via Ouro Medicines acquisition

Score
0.4
Velocity
▲ 0.0
Articles
4
Sources
2

Summary

An article belongs to this narrative if it discusses Gilead Sciences' acquisition of Ouro Medicines to bolster its inflammation and autoimmunity portfolio.

Related Articles

Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets

Yahoo Finance · Apr 04, 2026
Mixed

Gilead Sciences To Acquire Ouro Medicines

Nasdaq · Mar 24, 2026
Mixed

Sources

Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines … Yahoo Finance
Gilead Sciences's Q1 2026 Earnings: What to Expect Yahoo Finance
Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation … Yahoo Finance
Gilead Sciences To Acquire Ouro Medicines Nasdaq

Timeline

Last Updated Mar 24, 2026